
|Articles|September 1, 1999
The American Journal of Managed Care
- September 1999
- Volume 5
- Issue 9
Selective Contracting and Patient Outcomes: A Case Study of Formulary Restrictions for Selective Serotonin Reuptake Inhibitor Antidepressants
Advertisement
Articles in this issue
about 26 years ago
Is a Third-Trimester Antibody Screen in Rh+ Women Necessary?about 26 years ago
Drug Therapy of Allergic Rhinitisabout 26 years ago
Rethinking Formulary Strategy: Management and Measurement ConsiderationsNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Trump Announces Deals With Lilly, Novo to Cut Weight Loss Drug Prices
2
CMS Announces GENEROUS Model to Lower Medicaid Drug Prices
3
Medicare Advantage Reimbursement Structures Impact Home Health Delivery and Outcomes
4
Oncology Experts Spotlight Breakthrough Therapies, AI-Driven Care at PCOC 2025
5















































